Societies

Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Photo taken from Moderna/LinkedIn

Apr 9, 2024, 16:41

Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Quoting Moderna on LinkedIn:

“Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types, harnessing the body’s immune system to identify and kill cancer cells.

We believe the adaptability of mRNA technology can be leveraged to create an innovative and diverse portfolio of investigational cancer therapies, including individualized approaches.

Join us at AACR24 in San Diego at booth 441 as we continue to showcase the potential of mRNA technology and the possibility of changing cancer care and improving outcomes for patients.”

Source: Moderna/LinkedIn

AACR24 cancer Cancer research cancer therapies cancer treatment Innovation Medical Advancements Medical Technology mmuno-oncology Moderna mRNA OncoDaily Oncology San Diego

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage